I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Tyrosine kinase inhibitors vandetanib, lenvatinib and caboz..:
Kolarik, Matus
;
Indra, Radek
;
Adam, Vojtech
...
Kolarik , M , Indra , R , Adam , V , Heger , Z , Kopeckova , K , Arlt , V M & Stiborova , M 2019 , ' Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro ' , Neuroendocrinology Letters , vol. 39 , no. 7 , pp. 515-524 .. , 2019
Link:
https://kclpure.kcl.ac.uk/portal/en/publications/tyros..
RT Journal T1
Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro
UL https://suche.suub.uni-bremen.de/peid=base-ftkingscollondon:oai:pure.atira.dk:publications_2eef6f7b-9393-4843-b13c-1653061140bb&Exemplar=1&LAN=DE A1 Kolarik, Matus A1 Indra, Radek A1 Adam, Vojtech A1 Heger, Zbynek A1 Kopeckova, Katerina A1 Arlt, Volker M A1 Stiborova, Marie YR 2019 K1 Cytochromes P450 K1 Ellipticine K1 Ellipticine oxidation K1 Peroxidases K1 Tyrosine kinase inhibitors JF Kolarik , M , Indra , R , Adam , V , Heger , Z , Kopeckova , K , Arlt , V M & Stiborova , M 2019 , ' Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro ' , Neuroendocrinology Letters , vol. 39 , no. 7 , pp. 515-524 . LK http://dx.doi.org/https://kclpure.kcl.ac.uk/portal/en/publications/tyrosine-kinase-inhibitors-vandetanib-lenvatinib-and-cabozantinib-modulate-oxidation-of-an-anticancer-agent-ellipticine-catalyzed-by-cytochromes-p450-in-vitro(2eef6f7b-9393-4843-b13c-1653061140bb).html DO https://kclpure.kcl.ac.uk/portal/en/publications/tyrosine-kinase-inhibitors-vandetanib-lenvatinib-and-cabozantinib-modulate-oxidation-of-an-anticancer-agent-ellipticine-catalyzed-by-cytochromes-p450-in-vitro(2eef6f7b-9393-4843-b13c-1653061140bb).html SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)